ValiRx (LON:VAL) Issues Earnings Results

ValiRx (LON:VAL) released its earnings results on Monday. The company reported GBX (0.54) earnings per share for the quarter, Digital Look Earnings reports. ValiRx had a negative net margin of 3,582.56% and a negative return on equity of 45.91%. The business had revenue of GBX 3 million during the quarter.

ValiRx Trading Down 0.6%

Shares of LON:VAL opened at GBX 0.18 on Monday. The company’s 50-day moving average price is GBX 0.23 and its two-hundred day moving average price is GBX 0.30. ValiRx has a one year low of GBX 0.16 and a one year high of GBX 0.85. The company has a debt-to-equity ratio of 0.19, a current ratio of 9.66 and a quick ratio of 1.27. The stock has a market capitalization of £1.33 million, a PE ratio of -0.19 and a beta of 0.59.

About ValiRx

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.